4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001614740-25-000005
CHIEF EXECUTIVE OFFICER acquired 19,133 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Peetz Christopher · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-18 | Exercise or conversion : show line 1 in the form | +19,133 | $19.24 | $368,119 | 158,034 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-18 | Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) | −19,133 | 150,867 | D |
Loading xslF345X05/form4-11202025_091110.xml…